It is extremely difficult for most start-ups to break through bureaucratic procedures and, I think primarily through corporate procedures — Konstantin Noskov, Minister of Digital Development, Communications and Mass Media of the Russian Federation.
The first thing we encountered is a very long transaction cycle. It takes us more than 7 months on average to sign a contract with a pharmaceutical company: it's a lot for a start-up. <...> The second point is legislation. <...> There is a law that was recently adopted, the President signed it. <...> However, every time the Ministry of Health issues a new normative act that regulates the provision of such remote consultations. Every time it increasingly complicates the interaction between small players and more importantly between the big ones, the pharmaceutical companies — Dmitry Maznitsa, General Director, Founder, Qapsula.
Some players it takes a quarter just to sign a confidentiality agreement. <...> A quarter for a start-up – it’s like half a lifetime has already passed. The start-up is either already closed and money has run out, or the other way around: everything is fine, the star-up has already left the Russian Federation and now is a supplier in America or Germany — Dmitry Kalaev, , Director of Acceleration Programmes, Internet Initiative Development Fund .
Like any corporation, Bayer selects partners quite rigidly. We took our time signing the contract. <...> There was a lot of bureaucracy, plus the decision was made at different points, not only in Russia, but globally as well — Filipp Denisov, General Director, Founder, BrandQuad.